Oncology Cell Biology Medical Research Cancer Pharmacology Clinical Research Clinical Trials Immunology Cancer Treatment Genetics
It leverages CRISPR/Cas9 disruption of the interferon-γ receptor to boost CAR-T cell durability ahead of planned solid tumor trials.